Thermo Fisher Scientific Inc.
TMO
$590.83
-$2.42-0.41%
NYSE
| 09/27/2025 | 06/28/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 2.47% | 4.73% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 2.46% | 4.74% | |||
| Cost of Revenue | 1.37% | 5.28% | |||
| Gross Profit | 4.06% | 3.96% | |||
| SG&A Expenses | -1.04% | 2.96% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.67% | 4.62% | |||
| Operating Income | 10.69% | 5.27% | |||
| Income Before Tax | 6.84% | 6.54% | |||
| Income Tax Expenses | 125.00% | -3.16% | |||
| Earnings from Continuing Operations | 0.12% | 7.15% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -150.00% | 50.00% | |||
| Net Income | -0.06% | 7.30% | |||
| EBIT | 10.69% | 5.27% | |||
| EBITDA | 7.73% | 2.67% | |||
| EPS Basic | -0.06% | 7.30% | |||
| Normalized Basic EPS | 11.29% | 5.59% | |||
| EPS Diluted | -0.18% | 7.48% | |||
| Normalized Diluted EPS | 11.29% | 5.86% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | -0.26% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | 0.01% | 0.01% | |||